ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 626539 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 626539; 2) Community: the network communities that were significantly associated with the response to NSC 626539; 3) Molecule: the relationships between components within communities and NSC 626539; 4) MDR: the compounds that were significantly associated with the NSC 626539.

NSC Compound Enrichment Correlation
NSC 728035 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di 0.0414190425892871 0.36722819
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.0414190425892871 0.50575916
NSC 732178 Null 0.0414190425892871 0.23238586
NSC 733467 Null 0.0414190425892871 0.42716463
NSC 740476 Null 0.0414190425892871 0.3914432
NSC 748715 Null 0.0414190425892871 0.17268867
NSC 751152 3-(6/7-trifluoro-3-methyl-1,4-dioxy-quinoxaline-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone 0.0414190425892871 0.6432707
NSC 758881 Orlistat (USAN) 0.0414190425892871 0.27300717
NSC 759178 Pipamperone 0.0414190425892871 0.41705761
NSC 762559 Null 0.0414190425892871 -0.069944919
Total:89  Current:78    [First] [Prev] [Next] [Last]